Nicotine replacement therapy

7 marketed 3 in Phase 3

This page covers all Nicotine replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nicotinic acetylcholine receptors.

Targets

Nicotinic acetylcholine receptors

Marketed (7)

Phase 3 pipeline (3)